Connect with us

International

Epidyolex approved by the European Medicines Agency

Published

em

GW Pharmaceuticals announced on 23 September the Marketing Authorization (MA) approval of its anti-epileptic drug Epidyolex (Epidiolex in the United States) by the European Medicines Agency (EMA) as an orphan drug (drugs used in rare diseases) .

Epidiolex (cannabidiol oral solution) is the first cannabinoid-based drug (in this case CBD – cannabidiol), of plant origin, to have its AIM approved by the European Medicines Agency (EMA). In July 2019, the EMA's Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the drug, where it recommended deferring the MA application for this indication.

According to official document of the EMA, Epidyolex is used to treat seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged two years and over, together with Clobazam, in addition to the treatment of tuberous sclerosis . The EMA's approval was based on data from four phase III studies, which evaluated Epidiolex in 714 patients with LGS or Dravet syndrome. When added to other anti-epileptic therapies, Epidyolex significantly reduced seizure frequency in the patient population in question.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

Science11 hours ago

THCV may promote weight loss and generate therapeutic metabolic effects

A study with mucoadhesive strips containing tetrahydrocannabivarin (THCV) points to its potential in aiding weight loss, in addition to...

Chronicle12 hours ago

What can Japan learn from Europe's cannabis expos?

Introduction: When Cannabis Becomes Culture When we at the CBD Library posted on X (formerly Twitter) about what...

International1 hours ago

Patient criticizes quality of medicinal cannabis flowers supplied by Tikun Olam, company refutes allegations

Kelly Atzoutzoulas obtained a prescription from a Greek doctor for two units of Tikun Olam cannabis flower, with...

International2 days ago

Spain strengthens control of synthetic cannabinoids

Spain has taken steps to strengthen controls on psychotropic substances and synthetic cannabinoids through an update of Decree...

Hemp2 days ago

Italy declares CBD oil a narcotic

In a dramatic change for the Italian hemp industry, the Regional Administrative Court (TAR) has confirmed the classification of hemp oil as...

International2 days ago

Slovenia: What does the proposed regulation of cannabis in the country provide?

Slovenia has taken a step forward in cannabis legislation with the introduction of a new legislative proposal...

Press Releases2 days ago

SOMAÍ announces exclusive partnership with Sherbinskis and Boutiq

SOMAÍ Pharmaceuticals, a company based in Lisbon, has secured exclusive manufacturing and distribution rights for two of the most famous...

International2 days ago

Israel: Finance Minister opposes taxes on medical cannabis imported from Canada

Israeli Finance Minister Bezalel Smotrich has opposed a proposal to impose tariffs of up to 165% on imported cannabis...

International2 days ago

Kazakhstan approves legalization of industrial hemp

Kazakhstan's lower house of parliament, known as the Mazhilis, recently approved the cultivation of industrial hemp, a move that...

Events3 days ago

Premiere: Sensihemp brings hemp fashion to the 9th edition of Circular Sustainable Fashion Week (CSFW) in Madrid

The Portuguese brand Sensihemp, which is dedicated to sustainable and regenerative fashion based on hemp and natural dyes,...